Invention Grant
US09278083B2 Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
有权
纯化反式 - ( - ) - &Dgr; 9-四氢大麻酚和反 - (+) - &Dgr; 9-四氢大麻酚
- Patent Title: Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
- Patent Title (中): 纯化反式 - ( - ) - &Dgr; 9-四氢大麻酚和反 - (+) - &Dgr; 9-四氢大麻酚
-
Application No.: US14596034Application Date: 2015-01-13
-
Publication No.: US09278083B2Publication Date: 2016-03-08
- Inventor: Arie L. Gutman , Marina Etinger , Irina Fedotev , Ram Khanolkar , Gennady A. Nisnevich , Boris Pertsikov , Igor Rukhman , Boris Tishin
- Applicant: SVC Pharma LP
- Applicant Address: US NY Spring Valley
- Assignee: SVC Pharma LP
- Current Assignee: SVC Pharma LP
- Current Assignee Address: US NY Spring Valley
- Agency: Dechert LLP
- Main IPC: A61K31/352
- IPC: A61K31/352 ; C07D311/78 ; C07D311/80

Abstract:
Methods for making trans-(−)-Δ9-tetrahydrocannabinoI and trans-(+)-Δ9-tetrahydrocannabinol are disclosed herein. In one embodiment, a trans-(−)-Δ9-tetrahydrocannabinoI composition is prepared by allowing a composition comprising (±)-Δ9-tetrahydrocannabinol to separate on a chiral stationary phase to provide a trans-(−)-Δ9-tetrahydrocannabinoI composition comprising at least about 99% by weight of trans-(−)-Δ9-tetrahydrocannabinol based on the total amount of trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol. The invention also relates to methods for treating or preventing a condition such as pain comprising administering to a patient in need thereof an effective amount of a trans-(−)-Δ9-tetrahydrocannabinoI having a purity of at least about 98% based on the total weight of cannabinoids.
Public/Granted literature
- US20150126596A1 METHODS FOR PURIFYING TRANS-(-)-Delta9-TETRAHYDROCANNABINOL AND TRANS-(+)-Delta9-TETRAHYDROCANNABINOL Public/Granted day:2015-05-07
Information query